Anticancer Vigilance Of Cardiac Events (AVOCETTE) in Metastatic Colorectal Cancer

Caen University Hospital

Status: Unknown

Conditions: Colorectal Cancer Metastatic

Treatments: Drug: Antineoplastic Agents

Study type: Observational

Funder types: Other

Identifiers

NCT03923036

TPS 68479

Details and patient eligibility

About

This study is a retrospective observational study that evaluates the rate of cardiovascular adverse events leading to hospitalization in metastatic colorectal cancer in the French county Calvados by drug exposure.

Full description

This study investigates the characteristics of cardiovascular adverse events leading to hospitalization in metastatic colorectal cancer. Descriptive analysis will include incidence, type of cardiovascular adverse events.

We will explore the incidence of cardiovascular adverse events with regard of the antineoplastic drug exposures. This will provide information about the individual drug safety profiles.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with a metastatic colorectal cancer diagnosed between 2004 and 2014 in the French county Calvados

Exclusion criteria

• Minors < 18 year old
• Patients without a metastatic colorectal cancer diagnosed between 2004 and 2014 in the French county Calvados

Trial design

2,000 participants in 1 patient group

Metastatic colorectal cancer

Description:

The French county Calvados registry of digestive cancers will allow to identify patients with a metastatic colorectal cancer diagnosed between 2004 and 2014. Patients will be included if the cancer was diagnosed at the metastatic stage between 2004 and 2014 or non-metastatic before 2004 that became metastatic between 2004 and 2014 (synchronous and metachronous tumors)

Treatment:

Drug: Antineoplastic Agents